Departments of Medicine and Immunology, University of Manitoba, Winnipeg, Manitoba.
Allergy Asthma Clin Immunol. 2006 Jun 15;2(2):62-7. doi: 10.1186/1710-1492-2-2-62.
To retrospectively examine the relation between skin test reactivity, venom-specific immunoglobulin E (IgE) antibody levels, and severity of clinical reaction in patients with insect venom allergy.
Thirty-six patients (including 15 females) who presented with a history of allergic reactions to insect stings were assessed. The mean age at the time of the reactions was 33.4 +/- 15.1 years (range, 4-76 years), and patients were evaluated 43.6 +/- 90 months (range, 1-300 months) after the reactions. Clinical reactions were scored according to severity, from 1 (cutaneous manifestations only) to 3 (anaphylaxis with shock). These scores were compared to scores for skin test reactivity (0 to 5, indicating the log increase in sensitivity from 1 mug/mL to 0.0001 mug/mL) and radioallergosorbent test (RAST) levels (0 to 4, indicating venom-specific IgE levels, from undetectable to >17.5 kilounits of antigen per litre [kUA/L]).
No correlation was found between skin test reactivity (Spearman's coefficient = 0.15, p = .377) or RAST level (Spearman's coefficient = 0.32, p = .061) and the severity of reaction. Skin test and RAST scores both differed significantly from clinical severity (p < .05), but there was a significant correlation between skin test reactivity and RAST score (p = .042). There was no correlation between skin test reactivity and time since reaction (Spearman's coefficient = 0.18, p = .294) nor between RAST and time since reaction (r = 0.1353, p = .438). Elimination of patients tested more than 12 months after their reaction still produced no correlation between skin test reactivity (p = .681) or RAST score (p = .183) and the severity of the clinical reaction.
In venom-allergic patients (in contrast to reported findings in cases of inhalant IgE-mediated allergy), there appears to be no significant correlation between the degree of skin test reactivity or levels of venom-specific IgE (determined by RAST) and the severity of the clinical reaction.
回顾性研究皮肤试验反应、毒液特异性免疫球蛋白 E(IgE)抗体水平与昆虫毒液过敏患者临床反应严重程度之间的关系。
评估了 36 例(包括 15 例女性)有昆虫蜇伤过敏史的患者。反应时的平均年龄为 33.4 ± 15.1 岁(范围:4-76 岁),反应后评估时间为 43.6 ± 90 个月(范围:1-300 个月)。根据严重程度对临床反应进行评分,从 1(仅皮肤表现)到 3(伴有休克的过敏反应)。将这些评分与皮肤试验反应评分(0 至 5,指示从 1μg/ml 到 0.0001μg/ml 的敏感性对数增加)和放射过敏原吸附试验(RAST)水平(0 至 4,指示毒液特异性 IgE 水平,从不可检测到>17.5 千单位抗原/升[kUA/L])进行比较。
未发现皮肤试验反应(Spearman 系数=0.15,p=0.377)或 RAST 水平(Spearman 系数=0.32,p=0.061)与反应严重程度之间存在相关性。皮肤试验和 RAST 评分均与临床严重程度显著不同(p<0.05),但皮肤试验反应与 RAST 评分之间存在显著相关性(p=0.042)。皮肤试验反应与反应后时间之间无相关性(Spearman 系数=0.18,p=0.294),RAST 与反应后时间之间也无相关性(r=0.1353,p=0.438)。即使排除反应后 12 个月以上进行测试的患者,皮肤试验反应(p=0.681)或 RAST 评分(p=0.183)与临床反应严重程度之间也无相关性。
在对昆虫毒液过敏的患者中(与报道的吸入性 IgE 介导过敏的情况相反),皮肤试验反应程度或 RAST 确定的毒液特异性 IgE 水平与临床反应严重程度之间似乎没有显著相关性。